# Palivizumab

## Synagis inj 50mg/0.5mL

#### 一般可用

| 藥品代碼       | ISYNA1                                                                                                                                                                                                                                                                                                                                      |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease， including infants with bronchopulmonary dysplasia， a history of premature birth (<=35 weeks gestational age)， & children with hemodynamically significant congenital heart disease. |
| 用法用量       | IM， 15 mg/kg/month.                                                                                                                                                                                                                                                                                                                        |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                |
| 禁忌           | Hypersensitivity to palivizumab or humanized monoclonal antibodies.                                                                                                                                                                                                                                                                         |
| 副作用         | Upper respiratory infections， otitis media， rhinitis， rash， pain， hernia， increased SGOT， pharyngitis.                                                                                                                                                                                                                               |
| 孕期用藥建議   | No (limited) human data – no relevant animal data                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                         |

